Nova Eye Medical Limited (ASX:EYE)
Australia
· Delayed Price · Currency is AUD | Market Cap | 41.30M |
| Revenue (ttm) | 33.05M |
| Net Income (ttm) | -7.03M |
| Shares Out | 284.82M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 369,032 |
| Average Volume | 288,292 |
| Open | 0.145 |
| Previous Close | 0.150 |
| Day's Range | 0.145 - 0.147 |
| 52-Week Range | 0.086 - 0.205 |
| Beta | 0.81 |
| RSI | 37.73 |
| Earnings Date | May 26, 2026 |
About Nova Eye Medical
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma... [Read more]
Financial Performance
In fiscal year 2025, Nova Eye Medical's revenue was 29.27 million, an increase of 25.47% compared to the previous year's 23.33 million. Losses were -9.06 million, 3.06% more than in 2024.
Financial StatementsNews
Nova Eye Medical Limited (ELXMF) Shareholder/Analyst Call Transcript
Nova Eye Medical Limited (ELXMF) Shareholder/Analyst Call Transcript
Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript
Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript
Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript
Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript
Nova Eye Medical Limited (ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device Prepared Remarks Transcript
Nova Eye Medical Limited (OTCPK:ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device November 25, 2025 5:30 PM EST Company Participants Mark Flynn - Investor Re...
Nova Eye Medical Limited (ELXMF) Q1 2026 Earnings Call Transcript
Nova Eye Medical Limited (OTCPK:ELXMF) Q1 2026 Earnings Call November 4, 2025 7:30 PM EST Company Participants Mark Flynn - Investor Relations Thomas Spurling - MD & Executive Director Presentation Ma...